Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06354686 · ClinicalTrials.gov registry record · NA

Characterizing the Scalp Tolerability of TMS

A NA study of Healthy, sponsored by Florida State University.

Active
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT06354686 is a NA study of Healthy that is active but no longer recruiting, run by Florida State University. The registered enrollment target is 20 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06354686, a NA study of Healthy, is active but no longer recruiting, sponsored by Florida State University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The primary objective is to characterize the tolerability of TMS by scalp location (over parietal, motor, modified Beam F3 prefrontal, THREE-D prefrontal, orbitofrontal, and medial prefrontal) and stimulation parameters (single pulse, 10 Hz, theta burst). The secondary objective is to evaluate the knee as a surrogate location to safely trial tolerability of novel TMS parameters.

Conditions Studied

Interventions

  • DEVICE TMS Tolerability

Study Locations (1)

Florida

  • Florida State University - Tallahassee

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2024-02-12
Est. Completion 2027-05
Phase NA

Sponsor

Florida State University

219 total trials

What the Registry Record Tells You About NCT06354686

The ClinicalTrials.gov registry entry for NCT06354686 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (97% lower). The listed sponsor is Florida State University, which has 219 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which TMS Tolerability is the first listed.

NCT06354686 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT06354686 about?

NCT06354686 is a clinical study titled "Characterizing the Scalp Tolerability of TMS". The primary objective is to characterize the tolerability of TMS by scalp location (over parietal, motor, modified Beam F3 prefrontal, THREE-D prefrontal, orbitofrontal, and medial prefrontal) and stimulation parameters (single pulse, 10 Hz, theta burst). The secondary objective is to evaluate the k...

What is the current status of trial NCT06354686?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2024-02-12. Estimated completion is 2027-05.

What conditions does trial NCT06354686 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT06354686?

The interventions under investigation include: TMS Tolerability (DEVICE).

Who is sponsoring clinical trial NCT06354686?

This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06354686 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.